- JP-listed companies
- K Pharma,Inc.
K Pharma,Inc.JP:4896
Market cap
¥8.6B
P/E ratio
Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | |
Profit (loss) before income taxes | -229 | -391 | 301 |
Interest and dividend income | -0 | -0 | -0 |
Impairment losses | 8 | 31 | 43 |
Share issuance costs | 1 | 5 | 12 |
Going public expenses | - | - | 10 |
Other, net | - | 0 | 0 |
Decrease (increase) in inventories | -0 | -0 | -1 |
Increase (decrease) in trade payables | -0 | 7 | 2 |
Decrease (increase) in other current assets | 8 | -18 | -8 |
Increase (decrease) in other current liabilities | 9 | 2 | 97 |
Subtotal | -196 | -363 | 456 |
Interest and dividends received | 0 | 0 | 0 |
Income taxes paid | -0 | -1 | -2 |
Net cash provided by (used in) operating activities | -196 | -363 | 454 |
Purchase of property, plant and equipment | - | -30 | -10 |
Payments of leasehold and guarantee deposits | - | -3 | -1 |
Other, net | -0 | -0 | - |
Net cash provided by (used in) investing activities | -0 | -33 | -11 |
Proceeds from issuance of shares | 398 | 1,544 | 1,496 |
Going public expenses | - | - | -10 |
Other, net | - | -0 | -0 |
Net cash provided by (used in) financing activities | 368 | 1,544 | 1,486 |
Net increase (decrease) in cash and cash equivalents | 172 | 1,148 | 1,930 |